We have previously demonstrated direct tumor-promoting effects of visfatin on breast tumor cells mediated via c-Abl and STAT3 [36], and indirect effects via ADSC intermediaries acting via a GDF15-pAKT pathway [33]. The gene discussed is STAT3; the disease is breast neoplasm.